Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

151 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Review article: faecal transplantation therapy for gastrointestinal disease.
Landy J, Al-Hassi HO, McLaughlin SD, Walker AW, Ciclitira PJ, Nicholls RJ, Clark SK, Hart AL. Landy J, et al. Among authors: al hassi ho, hart al. Aliment Pharmacol Ther. 2011 Aug;34(4):409-15. doi: 10.1111/j.1365-2036.2011.04737.x. Epub 2011 Jun 20. Aliment Pharmacol Ther. 2011. PMID: 21682755 Review.
The microbiome in inflammatory bowel disease and beyond.
Landy J, Hart A. Landy J, et al. Clin Med (Lond). 2013 Dec;13 Suppl 6:s29-31. doi: 10.7861/clinmedicine.13-6-s29. Clin Med (Lond). 2013. PMID: 24298178
Editorial: prior response to infliximab and early serum drug concentrations predict effects of adalimumab in ulcerative colitis.
Hendy P, Hart A. Hendy P, et al. Aliment Pharmacol Ther. 2015 Jan;41(1):149. doi: 10.1111/apt.13011. Aliment Pharmacol Ther. 2015. PMID: 25483435 No abstract available.
Short-term efficacy and safety of three novel sphincter-sparing techniques for anal fistulae: a systematic review.
Adegbola SO, Sahnan K, Pellino G, Tozer PJ, Hart A, Phillips RKS, Warusavitarne J, Faiz OD. Adegbola SO, et al. Tech Coloproctol. 2017 Oct;21(10):775-782. doi: 10.1007/s10151-017-1699-4. Epub 2017 Oct 29. Tech Coloproctol. 2017. PMID: 29080959 Review.
Systematic review: predicting and optimising response to anti-TNF therapy in Crohn's disease - algorithm for practical management.
Ding NS, Hart A, De Cruz P. Ding NS, et al. Aliment Pharmacol Ther. 2016 Jan;43(1):30-51. doi: 10.1111/apt.13445. Epub 2015 Oct 30. Aliment Pharmacol Ther. 2016. PMID: 26515897 Review.
The body composition profile is associated with response to anti-TNF therapy in Crohn's disease and may offer an alternative dosing paradigm.
Ding NS, Malietzis G, Lung PFC, Penez L, Yip WM, Gabe S, Jenkins JT, Hart A. Ding NS, et al. Aliment Pharmacol Ther. 2017 Nov;46(9):883-891. doi: 10.1111/apt.14293. Epub 2017 Sep 7. Aliment Pharmacol Ther. 2017. PMID: 28881017
Systematic review: interventions for abdominal pain management in inflammatory bowel disease.
Norton C, Czuber-Dochan W, Artom M, Sweeney L, Hart A. Norton C, et al. Aliment Pharmacol Ther. 2017 Jul;46(2):115-125. doi: 10.1111/apt.14108. Epub 2017 May 4. Aliment Pharmacol Ther. 2017. PMID: 28470846 Review.
Relapse after withdrawal from anti-TNF therapy for inflammatory bowel disease: an observational study, plus systematic review and meta-analysis.
Kennedy NA, Warner B, Johnston EL, Flanders L, Hendy P, Ding NS, Harris R, Fadra AS, Basquill C, Lamb CA, Cameron FL, Murray CD, Parkes M, Gooding I, Ahmad T, Gaya DR, Mann S, Lindsay JO, Gordon J, Satsangi J, Hart A, McCartney S, Irving P; UK Anti-TNF withdrawal study group, Lees CW. Kennedy NA, et al. Aliment Pharmacol Ther. 2016 Apr;43(8):910-923. doi: 10.1111/apt.13547. Epub 2016 Feb 19. Aliment Pharmacol Ther. 2016. PMID: 26892328 Free PMC article. Review.
Commentary: The effects of probiotics on barrier function and mucosal pouch microbiota during maintenance treatment for severe pouchitis in patients with ulcerative colitis.
Landy J, Hart A. Landy J, et al. Aliment Pharmacol Ther. 2013 Dec;38(11-12):1405-6. doi: 10.1111/apt.12517. Aliment Pharmacol Ther. 2013. PMID: 24206372 No abstract available.
Commentary: is Faecalibacterium prausnitzii a potential treatment for maintaining remission in ulcerative colitis?
Siaw YH, Hart A. Siaw YH, et al. Aliment Pharmacol Ther. 2013 Sep;38(5):551. doi: 10.1111/apt.12404. Aliment Pharmacol Ther. 2013. PMID: 23937459 No abstract available.
151 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback